beta-lactams has been researched along with amoxicillin in 124 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (amoxicillin) | Trials (amoxicillin) | Recent Studies (post-2010) (amoxicillin) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 10,915 | 2,661 | 3,467 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (21.77) | 18.7374 |
1990's | 10 (8.06) | 18.2507 |
2000's | 32 (25.81) | 29.6817 |
2010's | 36 (29.03) | 24.3611 |
2020's | 19 (15.32) | 2.80 |
Authors | Studies |
---|---|
Joly, J; Kraytman, M; Ninane, G; Piot, P | 1 |
Dessens-Kroon, M; Van Klingeren, B | 1 |
Bodey, GP; LeBlanc, BM; Weaver, SS | 1 |
Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
Neu, HC | 1 |
Livermore, DM; Seetulsingh, P | 1 |
Almodovar, E; Burdette, M; Kroschinsky, R; Qadri, SM; Ueno, Y | 1 |
Coleman, K; Griffin, DR; Page, JW; Upshon, PA | 1 |
Płotkowiak, Z | 1 |
Ball, AP; Brookes, GR; Davey, PG; Farrell, ID; Geddes, AM | 1 |
D'Costa, LJ; Fast, MV; Karasira, P; Maclean, IW; Nsanze, H; Plummer, FA; Ronald, AR | 1 |
Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN | 1 |
Ansink-Schipper, MC; Coster, JF; Coutinho, RA; De Koning, GA; Tio, D | 1 |
O'Grady, FW | 1 |
Piot, P; Van Dyck, E | 1 |
Hashimoto, T; Matsuura, M; Mitsuhashi, S; Nakazawa, H | 1 |
Basker, MJ; Boon, RJ; Hunter, PA | 1 |
Coleman, K; Fisher, J; Hunter, PA; Taylor, D | 1 |
Bradnock, K; Leigh, DA; Marriner, JM | 1 |
Albritton, WL; Girouard, YC; Maclean, IW; Ronald, AR | 1 |
Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
Rolinson, GN | 1 |
De Klerk, HC; Forder, AA; Gricius, ME; Hallett, AF; Koornhof, HJ; Lindeque, KP; Neiteler, BF; Robinson, R; Van den Ende, J; Van Rensburg, AJ; Venter, L | 1 |
Celliers, D; Du Plessis, DJ; Lindeque, KP; Van Rensburg, AJ | 1 |
Hatzimichelakis, N; Kontomichalou, P; Makris, G; Paniara-Volika, O; Paraskevopoulou, E; Saroglou, G; Sima, A; Vassilopoulos, N | 1 |
Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Ulmer, WT; Zimmermann, I | 1 |
Avery, GS; Brogden, RN; Carmine, A; Heel, RC; Morley, PA; Speight, TM | 1 |
Baker, S; Cadge, B; Durham, SR; Gillett, AP; Wise, R | 1 |
Bergogne-Berezin, E; Lambert-Zechovsky, N; Muller-Serieys, C; Picard, B; Vanjak, D | 1 |
Andrews, JM; Brenwald, N; Wise, R | 1 |
Gaviraghi, G; Perboni, A; Salvatori, A; Spadoni, G; Tamburini, B; Tarzia, G; Xerri, L | 1 |
Amicosante, G; Fattorini, L; Franceschini, N; Orefici, G; Scopetti, F | 1 |
Verbist, L; Verhaegen, J | 1 |
Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C | 1 |
Matsuda, K; Matsumoto, S; Matsumoto, Y; Sasaki, H; Takasugi, H; Yoshida, Y | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Blanca, M; José Torres, M; Juárez, C; Leyva, L; Luque, I; Mayorga, C; Rosal, M; Segura, JM | 1 |
Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I; Prieto, J; Yuste, J | 1 |
Mitsuno, Y; Yoshida, H | 1 |
Andrews, JM; Ashby, JP; Boswell, FJ; Wise, R | 1 |
Boosten, WH; Bukhanov, AL; Moody, HM; Svedas, VK; Youshko, MI | 1 |
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
Aguado-García, JM; Lumbreras-Bermejo, C; Martín-Herrero, JE | 1 |
Behra-Miellet, J; Calvet, L; Dubreuil, L | 1 |
Arvieux, C; Desbordes, L; Dupont, M; Flicoteaux, R; Le Tulzo, Y; Michelet, C; Tattevin, P; Tribut, O | 1 |
Hosaka, Y; Inoue, M; Kaieda, S; Okamoto, R; Okitsu, N; Takahashi, H; Yano, H | 1 |
Dittrich, E; Guttmann, C; Meyer, B; Schmaldienst, S; Thalhammer, F | 1 |
Toltzis, P | 1 |
Cebrián, L; Escribano, I; Rodríguez, JC; Royo, G | 1 |
Beitsma, M; Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Nakayama, H; Saika, T; Tanaka, M; Tatewaki, M | 1 |
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
Antunez, C; Blanca, M; Fernandez, TD; Lopez, S; Mayorga, C; Rodriguez-Pena, R; Torres, MJ | 1 |
Alpízar-Lorenzo, JM; Cerdà, V; González-San Miguel, HM | 1 |
De Zutter, L; Okerman, L; Van Hende, J | 1 |
Bröcker, EB; Gross, GE; Seitz, CS; Trautmann, A; Trcka, J | 1 |
Hall, AJ; Moreno-Bondi, MC; Orellana, G; Sellergren, B; Urraca, JL | 1 |
Anuradha, K; Lakshmi, V; Sailaja, VV; Satheesh, T; Umabala, P | 1 |
Cohen, R; Grimprel, E | 1 |
Fernandez-Lafuente, R; Ferreira, AL; Giordano, RC; Giordano, RL; Gonçalves, LR; Guisan, JM | 1 |
Aguilar, L; Alou, L; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M; Valdes, L | 1 |
Barcelona, L; Marín, M; Stamboulian, D | 1 |
Lightfield, AR; Mastovska, K | 1 |
Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED | 1 |
Erić, M; Sabo, A | 1 |
Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N | 1 |
Anderson, GD; Andrew, MA; Grady, RW; Li, M; Phillips, B; Salinger, DH; Shen, DD; Vicini, P; Wang, J | 1 |
Korosec, P; Kosnik, M; Silar, M; Vegnuti, M; Zidarn, M | 1 |
Del Prado, G; García, E; Huelves, L; Naves, P; Ponte, C; Rodríguez-Cerrato, V; Ruiz, V; Soriano, F | 1 |
Cerić, H; Kovacević, M; Perić, M; Sindler-Kulyk, M; Zivković, A | 1 |
Lam, JC; Lam, PK; Leung, HW; Martin, M; Minh, TB; Murphy, MB; Richardson, BJ; So, MK | 1 |
Fujiwara, K; Miyazaki, T; Saita, T; Shin, M; Yoshizaki, Y | 1 |
Carbonnelle, S; De Bel, A; Dediste, A; Glupczynski, Y; Huang, TD; Jacobs, F; Jordens, P; Lismond, A; Schatt, P; Tulkens, PM; Van Bambeke, F; Verhaegen, J; Verschuren, F | 1 |
Dabernat, H; Delmas, C | 1 |
Crea, F; Cucinotta, D; De Stefano, C; Milea, D; Sammartano, S; Vianelli, G | 1 |
Drobniewski, F; Gonzalo, X | 1 |
Berbari, E; Huddleston, P; Ramos, A | 1 |
Aly, SA; Boothe, DM; Debavalya, N; Oryazabal, OA; Suh, SJ | 1 |
Ashar, TK; Bečka, S; Datla, A; Dobišová, M; Grulich, M; Kyslík, P; Marešová, H; Maršálek, J; Palyzová, A; Plačková, M; Plháčková, K; Štěpánek, V; Valešová, R; Vyasarayani, RW | 1 |
Ariza, A; Blanca, M; Corzo, JL; Mayorga, C; Muñoz, C; Requena, G; Torres, MJ; Urda, A; Zambonino, MA | 1 |
Ariza, A; Blanca, M; Cañada, FJ; Collado, D; Montañez, MI; Pérez-Inestrosa, E; Pérez-Sala, D; Torres, MJ; Vida, Y | 1 |
Ariza, A; Barrionuevo, E; Blanca, M; Fernández, TD; Guéant, JL; Mayorga, C; Montañez, MI; Perez-Inestrosa, E; Rodríguez-Guéant, RM; Ruiz-Sánchez, A; Torres, MJ | 1 |
Iranifam, M; Khabbaz Kharameh, M | 1 |
Altay, MA; Baur, DA; Flores-Hidalgo, A; Ort, Y; Quereshy, FA | 1 |
Coates, A; Hu, Y; Kearns, A; Liu, A; McTavish, SM; Moigboi, C; Vaiciunaite, B; Vaudrey, J | 1 |
Kumar, M; Singhal, N; Srivastava, A; Virdi, JS | 1 |
Ariza, A; Blanca, M; Fernandez, TD; Gomez, E; Lopez, S; Mayorga, C; Pozo, D; Sanz, ML; Torres, MJ | 1 |
Bayles, KW; Callahan, MT; Endres, JL; Farmer, JT; Horswill, AR; Kaplan, JB; Marchand, M; Mlynek, KD; Shimkevitch, AV | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Blanca, M; González-Morena, JM; Pérez-Inestrosa, E; Pérez-Sala, D; Sánchez-Gómez, FJ; Torres, MJ; Vida, Y | 1 |
Confino-Cohen, R; Goldberg, A; Lachover, I; Meir Shafrir, K; Rosman, Y | 1 |
Ariza, A; Doña, I; Guzmán, AE; Martín-Serrano, Á; Mayorga, C; Montañez, MI; Pérez-Inestrosa, E; Pérez-Sala, D; Salas, M; Torres, MJ | 1 |
Bento, C; Raposo, J; Sales, F; Teotónio, R | 1 |
Branda, JA; Hovius, JW; Hu, LT; Li, X; Mead, PS; Steere, AC; Strle, F; Wormser, GP | 1 |
Durand-Alegría, JS; Fernández-Hernando, P; Garcinuño-Martínez, RM; Soledad-Rodríguez, B | 1 |
Abat, C; Diene, SM; Raoult, D; Rolain, JM | 1 |
Babington, R; Broto, M; Corominas, M; Galve, R; Lleonart, R; Marco, MP; Matas, S | 1 |
Ansari, M; Munir, T; Saad, N | 1 |
Cecchini, J; Habibi, A; Hulin, A; Mekontso Dessap, A; Razazi, K | 1 |
Felix, LM; Kaehne, A; Marsden, PA; Milan, SJ; Sheridan, E; Spencer, S | 1 |
Borowska, E; Bräse, S; Horn, H; Majewsky, M; Merel, S; Timm, A; Zwiener, C | 1 |
Blumenthal, KG; Macy, E; Rowe, T; Shenoy, ES | 1 |
Shi, D; Wang, X; Xiao, Q; Xiao, Y; Zhang, Y; Zhou, Q | 1 |
Benachour, A; Budin-Verneuil, A; Cacaci, M; Hartke, A; Léger, L; Verneuil, N | 1 |
Gans, MD; Jerschow, E; Tejera, DS | 1 |
Abrams, EM; Atkinson, A; Ben-Shoshan, M; Delli Colli, L; Eiwegger, T; Gabrielli, S; Lavine, E; McCusker, C; O'Keefe, A; Pitt, T; Protudjer, JLP | 1 |
Conceição, N; da de Cunha Hueb Barata Oliveira, C; da Silva, LEP; de Oliveira, AG; de Oliveira, KLP; de Souza, LRC; Rodrigues, WF | 1 |
Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
Bourrain, JL; Chiriac, AM; Demoly, P; Pérez-Codesido, S | 1 |
Alharbi, M; Alharbi, O; Biboy, J; Derrick, JP; Gallagher, LA; Grunert, T; Ingmer, H; Liu, H; Mayer, K; McBain, AJ; Mikkelsen, K; Nøhr-Meldgaard, K; O'Gara, JP; Sirisarn, W; Vestergaard, M; Vollmer, W; Xia, G | 1 |
Courter, J; Mortensen, JE; Murphy, ME; Powell, E | 1 |
Alcouffe, O; Chagneau, CV; Grare, M; Massip, C; Oswald, E | 1 |
Arkell, P; Gilchrist, M; Holmes, AH; Hope, W; Rawson, TM; Riezk, A; Wheeler, G; Wilson, RC | 1 |
Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR | 1 |
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
Dartois, V; Dick, T; Negatu, DA; Zimmerman, MD | 1 |
Canals, F; Forniés, MJ; García-Avilés, B; González, MC; Latorre, S; Marco, N; Moral, L; Toral, T | 1 |
Gehlot, P; P, H | 1 |
Cannizzo, FT; Cuccato, M; Laconi, A; Mughini-Gras, L; Piccirillo, A; Tolosi, R | 1 |
Albert, R; Caillault, L; Dorel, M; Lalanne, S; Le Bot, A; Lemaignen, A; Revest, M; Tattevin, P; Verdier, MC | 1 |
Aydin, O; Celik, GE; Dogu, F; Guloglu Karatas, D; Ikinciogullari, A | 1 |
Armentano, D; Bartella, L; Di Donna, L; Escamilla, P; Ferrando-Soria, J; Leyva-Pérez, A; Marino, T; Pardo, E; Percoco, RM; Prejanò, M; Sanz-Navarro, S | 1 |
Ahmed, A; Anwaar, F; Ghumman, NZ; Ijaz, M; Javed, MU; Muzammil, I; Rasheed, H; Raza, A | 1 |
10 review(s) available for beta-lactams and amoxicillin
Article | Year |
---|---|
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
Topics: Amoxicillin; Animals; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Half-Life; Humans; Intestinal Absorption; Mice; Respiratory Tract Infections; Sexually Transmitted Diseases; Tissue Distribution; Urinary Tract Infections | 1981 |
[Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; beta-Lactams; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Spain; Streptococcus pneumoniae | 2004 |
Comparison of amoxicillin with alternative agents for the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Child; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Otitis Media | 2005 |
[Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].
Topics: Acute Disease; Administration, Oral; Age Factors; Amoxicillin; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactams; Cephalosporins; Child; Clindamycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Meta-Analysis as Topic; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2007 |
[Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sulbactam | 2008 |
Diagnosis and treatment of Fusobacterium nucleatum discitis and vertebral osteomyelitis: case report and review of the literature.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Braces; Clavulanic Acid; Combined Modality Therapy; Discitis; Drug Therapy, Combination; Ertapenem; Female; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Treatment Outcome | 2013 |
Lyme borreliosis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Borrelia burgdorferi; Borrelia burgdorferi Group; Cefuroxime; Doxycycline; Exanthema; Humans; Ixodes; Lyme Disease; Lyme Neuroborreliosis; Risk Factors; Zoonoses | 2016 |
Head-to-head trials of antibiotics for bronchiectasis.
Topics: Adult; Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Bronchiectasis; Child; Fluoroquinolones; Forced Expiratory Volume; Humans; Polymyxins; Pseudomonas Infections; Randomized Controlled Trials as Topic | 2018 |
Evaluation and Management of Penicillin Allergy: A Review.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Immunologic Tests; Patient Acuity; Penicillins; Pregnancy | 2019 |
Addition of probenecid to oral β-lactam antibiotics: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Gonorrhea; Humans; Monobactams; Probenecid | 2022 |
5 trial(s) available for beta-lactams and amoxicillin
Article | Year |
---|---|
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
Topics: Administration, Oral; Amoxicillin; Bacteriuria; beta-Lactamase Inhibitors; beta-Lactams; Biological Products; Carboxylic Acids; Clavulanic Acid; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptomyces; Tablets; Urinary Tract Infections | 1980 |
Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chancroid; Clavulanic Acid; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Haemophilus ducreyi; Humans; Male; Random Allocation | 1982 |
A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Bronchitis; Clavulanic Acid; Clinical Trials as Topic; Doxycycline; Drug Combinations; Humans; Middle Aged | 1981 |
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefpodoxime; Ceftizoxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Immunoglobulin E; Male; Middle Aged; Penicillin V; Single-Blind Method; Skin Tests; Treatment Outcome | 2007 |
109 other study(ies) available for beta-lactams and amoxicillin
Article | Year |
---|---|
Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
Topics: Aged; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Humans; Male; Middle Aged; Neisseriaceae; Penicillinase; Respiratory Tract Infections | 1978 |
The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Interactions; Haemophilus influenzae; Microbial Sensitivity Tests | 1979 |
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbenicillin; Penicillin Resistance; Penicillins; Staphylococcus aureus; Streptococcus pyogenes; Thienamycins; Ticarcillin | 1979 |
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acid; Escherichia coli; Female; Humans; Middle Aged; Proteus mirabilis; Urinary Tract Infections | 1979 |
Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
Topics: Aminoglycosides; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbenicillin; Cephalosporins; Culture Media; Drug Synergism; Electric Conductivity; Microbial Sensitivity Tests; Osmolar Concentration; Penicillin G; Penicillins | 1977 |
Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
Evaluation of BRL 42715, a beta-lactamase-inhibiting penem.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests | 1991 |
In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acids; Drug Synergism; Lactams; Microbial Sensitivity Tests; Sulbactam | 1989 |
The effect of the chemical character of certain penicillins on the resistance of the beta-lactam group in their molecules. Part 5: Kinetics of thermal decomposition in solid state.
Topics: Amoxicillin; beta-Lactams; Chemical Phenomena; Chemistry, Physical; Kinetics; Penicillins; Thermodynamics | 1987 |
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus | 1981 |
The combination of clavulanic acid and amoxycillin (Augmentin) in the treatment of patients infected with penicillinase producing gonococci.
Topics: Amoxicillin; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Therapy, Combination; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillinase | 1981 |
Twenty-one years of beating beta-lactamases.
Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Penicillin Resistance | 1982 |
In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Clavulanic Acid; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Neisseriaceae; Penicillins | 1982 |
Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Kinetics; Penicillin Resistance | 1980 |
Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Drug Synergism; Lactams; Microbial Sensitivity Tests; Structure-Activity Relationship | 1980 |
In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Penicillins; Protein Binding; Ticarcillin | 1980 |
Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillin Resistance; Urinary Tract Infections | 1981 |
Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Synergism; Haemophilus | 1981 |
Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients.
Topics: Amoxicillin; beta-Lactams; Child; Clavulanic Acid; Drug Combinations; Half-Life; Humans; Kinetics; Penicillinase; Suspensions; Time Factors | 1982 |
The history and background of Augmentin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Drug Combinations; Enzyme Inhibitors; Penicillin Resistance | 1982 |
The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Penicillin Resistance | 1982 |
[Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Combinations; Enzyme Inhibitors; Humans; Spinal Injuries; Urinary Tract Infections | 1982 |
Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; beta-Lactams; Bronchitis; Clavulanic Acid; Drug Combinations; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1982 |
A study of clavulanate-amoxicillin synergy using a triple layer technique and enzymatic neutralization.
Topics: Amoxicillin; Bacteria; Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Culture Media; Drug Synergism; Penicillinase | 1980 |
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Blister; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Floxacillin; Humans; Imidazolidines; Male; Penicillins; Protein Binding | 1980 |
Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Isoelectric Focusing; Microbial Sensitivity Tests | 1995 |
In vitro activity of the tricyclic beta-lactam GV104326.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefuroxime; Ciprofloxacin; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae | 1996 |
Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Lactams; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 1996 |
Non-inducible, mainly cell-associated beta-lactamase from Nocardia asteroides strain 108.
Topics: Amoxicillin; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefoxitin; Detergents; Hydrolysis; Isoelectric Point; Mutagenesis; Mutation; Nocardia asteroides; Penicillin G | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
Topics: Acute Disease; Amoxicillin; beta-Lactam Resistance; beta-Lactams; Cefpodoxime; Ceftizoxime; Cefuroxime; Erythromycin; France; Humans; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Penicillins; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clarithromycin; Disease Models, Animal; Helicobacter pylori; Lactams; Mice; Molecular Structure | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions.
Topics: Adult; Aged; Amoxicillin; Benzeneacetamides; beta-Lactams; Drug Hypersensitivity; Female; Humans; Hypersensitivity; Hypersensitivity, Immediate; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Penicillin G; Polylysine; Radioallergosorbent Test; Sensitivity and Specificity; Skin Tests; Statistics, Nonparametric; T-Lymphocytes | 2001 |
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.
Topics: Amoxicillin; Animals; Antibodies, Bacterial; Antibody Specificity; beta-Lactams; Cefotaxime; Disease Models, Animal; Humans; Immune Sera; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae; Treatment Outcome | 2002 |
Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Humans; Lactams; Microbial Sensitivity Tests; Protein Binding; Serum Albumin; Staphylococcus aureus | 2002 |
Penicillin acylase-catalyzed synthesis of beta-lactam antibiotics in highly condensed aqueous systems: beneficial impact of kinetic substrate supersaturation.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Catalysis; Cephalexin; Cephalosporins; Enzyme Activation; Escherichia coli; Kinetics; Penicillanic Acid; Penicillin Amidase; Solutions; Substrate Specificity; Water | 2004 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
A Bacteroides thetaiotamicron porin that could take part in resistance to beta-lactams.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroides; beta-Lactam Resistance; beta-Lactams; Clavulanic Acid; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Porins | 2004 |
Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Endocarditis, Bacterial; Female; Gram-Positive Cocci; Humans; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2005 |
In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefaclor; Ceftriaxone; Dose-Response Relationship, Drug; Haemophilus paragallinarum; Imipenem; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Time Factors | 2005 |
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Treatment Outcome | 2005 |
In vitro generation of Salmonella spp. mutants following repeated exposure to beta-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation; Salmonella | 2006 |
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Europe; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Polymerase Chain Reaction; Population Surveillance; Sequence Analysis, DNA | 2006 |
In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Drug Synergism; Humans; Male; Neisseria gonorrhoeae | 2006 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
Topics: Adult; Amoxicillin; Antigen Presentation; beta-Lactams; Cell Differentiation; Cells, Cultured; Dendritic Cells; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; T-Lymphocytes | 2006 |
Simultaneous determination of beta-lactamic antibiotics by a new high-performance low-pressure chromatographic system using a multisyringe burette coupled to a monolithic column (MSC).
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; Chromatography, High Pressure Liquid; Excipients; Sensitivity and Specificity; Solvents | 2007 |
Stability of frozen stock solutions of beta-lactam antibiotics, cephalosporins, tetracyclines and quinolones used in antibiotic residue screening and antibiotic susceptibility testing.
Topics: Agar; Amoxicillin; Bacillus subtilis; beta-Lactams; Cephalosporins; Chemistry Techniques, Analytical; Drug Residues; Hydrogen-Ion Concentration; Methanol; Quinolones; Temperature; Tetracyclines; Time Factors | 2007 |
Molecularly imprinted polymers as antibody mimics in automated on-line fluorescent competitive assays.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Antibody Specificity; Automation; beta-Lactams; Binding, Competitive; Chromatography; Fluoroimmunoassay; Molecular Mimicry; Nafcillin; Oxacillin; Penicillanic Acid; Penicillin G; Penicillin V; Polymers; Sensitivity and Specificity | 2007 |
Sensitivity pattern of gram negative bacilli to three beta-lactam/beta-lactamase inhibitor combinations using the automated API system.
Topics: Acinetobacter; Amoxicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas; Stenotrophomonas; Tazobactam; Ticarcillin | 2007 |
Influence of mass transfer limitations on the enzymatic synthesis of beta-lactam antibiotics catalyzed by penicillin G acylase immobilized on glioxil-agarose.
Topics: Amoxicillin; Ampicillin; beta-Lactams; Catalysis; Computer Simulation; Enzymes, Immobilized; Membranes, Artificial; Models, Chemical; Penicillin Amidase; Sepharose | 2008 |
Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
Topics: Amoxicillin; beta-Lactams; Blood Bactericidal Activity; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 2008 |
Streamlining methodology for the multiresidue analysis of beta-lactam antibiotics in bovine kidney using liquid chromatography-tandem mass spectrometry.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cephalosporins; Chromatography, Liquid; Cloxacillin; Kidney; Penicillins; Reproducibility of Results; Tandem Mass Spectrometry | 2008 |
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin | 2009 |
Teratogenicity of antibacterial agents.
Topics: Abnormalities, Drug-Induced; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; Female; Fetus; Humans; Infant, Newborn; Longitudinal Studies; Maternal-Fetal Exchange; Pregnancy; Prevalence; Serbia | 2008 |
Levofloxacin-induced delirium.
Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment | 2009 |
Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Beverages; Cefaclor; Drug Interactions; Female; Humans; Vaccinium macrocarpon; Young Adult | 2009 |
The specificity of tests for anti-beta-lactam IgE antibodies declines progressively with increase of total serum IgE.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Antibody Specificity; beta-Lactams; Drug Hypersensitivity; Epitopes; False Positive Reactions; Female; Humans; Immunoglobulin E; Intradermal Tests; Male; Middle Aged; Penicillin G; Penicillin V | 2009 |
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Mice; Microbial Sensitivity Tests; Microbial Viability; Novobiocin; Peritoneum; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae; Survival Analysis; Treatment Outcome | 2010 |
Azetidinone-isothiazolidinones: stereoselective synthesis and antibacterial evaluation of new monocyclic beta-lactams.
Topics: Amoxicillin; Anti-Bacterial Agents; Azetidines; Bacteria; Microbial Sensitivity Tests; Molecular Structure; Monobactams; Stereoisomerism; Thiazolidines | 2010 |
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; China; Chloramphenicol; Drug Utilization; Environmental Monitoring; Erythromycin; Fluoroquinolones; Hong Kong; Humans; Macrolides; Ofloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.
Topics: Absorption; Administration, Oral; Amoxicillin; Animals; beta-Lactams; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Immunohistochemistry; Intestine, Small; Kidney; Leucine; Male; Peptide Transporter 1; Rats; Rats, Wistar; Symporters | 2011 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; beta-Lactams; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Vaccination; Young Adult | 2012 |
Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Bronchi; Child, Preschool; Conjunctiva; Databases, Factual; Drug Resistance, Multiple, Bacterial; Ear, Middle; Evolution, Molecular; France; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Nasopharynx; Population Surveillance; Prevalence; Retrospective Studies | 2012 |
Modeling solubility, acid-base properties and activity coefficients of amoxicillin, ampicillin and (+)6-aminopenicillanic acid, in NaCl(aq) at different ionic strengths and temperatures.
Topics: Amoxicillin; Ampicillin; beta-Lactams; Hydrogen-Ion Concentration; Hydrolysis; Osmolar Concentration; Penicillanic Acid; Potentiometry; Sodium Chloride; Solubility; Solutions; Temperature; Water | 2012 |
Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2013 |
Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administration.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA Gyrase; DNA Topoisomerase IV; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Proteins; Feces; Fluoroquinolones; Gene Transfer, Horizontal; Mutation; Plasmids; Polymerase Chain Reaction | 2012 |
Penicillin G acylase from Achromobacter sp. CCM 4824 : an efficient biocatalyst for syntheses of beta-lactam antibiotics under conditions employed in large-scale processes.
Topics: Achromobacter; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Biotransformation; Enzyme Stability; Enzymes, Immobilized; Hydrogen-Ion Concentration; Penicillanic Acid; Penicillin Amidase; Temperature | 2014 |
Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children.
Topics: Adolescent; Amoxicillin; beta-Lactams; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Immunization; Immunoglobulin E; Infant; Male; Population Groups; Skin Tests | 2014 |
Study of protein haptenation by amoxicillin through the use of a biotinylated antibiotic.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Biotinylation; Butylamines; Haptens; Humans; Hypersensitivity; Immunoglobulin E; Macrophages; Mice; Microscopy, Confocal; Molecular Structure; Serum Albumin | 2014 |
IgE to penicillins with different specificities can be identified by a multiepitope macromolecule: Bihaptenic penicillin structures and IgE specificities.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antibody Affinity; Antibody Specificity; beta-Lactams; Drug Hypersensitivity; Epitopes; Female; Haptens; Humans; Hypersensitivity, Immediate; Immunoassay; Immunoglobulin E; Male; Middle Aged; Penicillin G; Penicillins; Radioallergosorbent Test; Skin Tests; Young Adult | 2014 |
Cupric oxide nanoparticles-enhanced chemiluminescence method for measurement of β-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Copper; Hydrogen Peroxide; Limit of Detection; Luminescent Measurements; Luminol; Microscopy, Electron, Transmission; Nanoparticles; X-Ray Diffraction | 2015 |
Chronic osteomyelitis of the mandible: diagnosis and management--an institution's experience over 7 years.
Topics: Administration, Intravenous; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Chronic Disease; Clindamycin; Doxycycline; Ertapenem; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Male; Mandibular Diseases; Mandibular Fractures; Middle Aged; Osteomyelitis; Osteosclerosis; Retrospective Studies; Sulbactam; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Amoxicillin; Animals; beta-Lactams; Female; Gentamicins; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Penicillins; Peptides; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; DNA-Binding Proteins; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Hydrogen Bonding; Models, Molecular; Molecular Docking Simulation; Nucleic Acid Conformation; Promoter Regions, Genetic; RNA, Messenger; Yersinia enterocolitica | 2014 |
Betalactam antibiotics affect human dendritic cells maturation through MAPK/NF-kB systems. Role in allergic reactions to drugs.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cell Differentiation; Dendritic Cells; Down-Regulation; Drug Hypersensitivity; Endocytosis; Female; Humans; Male; MAP Kinase Signaling System; Middle Aged; Monocytes; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; T-Lymphocytes; Up-Regulation | 2015 |
Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Biofilms; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus | 2016 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Amoxicillin haptenates intracellular proteins that can be transported in exosomes to target cells.
Topics: Amoxicillin; B-Lymphocytes; beta-Lactams; Exosomes; Haptens; Humans; Protein Binding; Protein Transport; Proteins; Proteome; Proteomics | 2017 |
The Importance of Amoxicillin and Amoxicillin-Clavulanate Determinants in the Diagnosis of Immediate Allergic Reactions to β-Lactams.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Child; Child, Preschool; Drug Hypersensitivity; Epitopes; Female; Humans; Hypersensitivity, Immediate; Infant; Male; Middle Aged; Skin Tests; Young Adult | 2016 |
The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams.
Topics: Adult; Aged; Amoxicillin; Anaphylaxis; Antibody Specificity; beta-Lactams; Butylamines; Carrier Proteins; Cross Reactions; Drug Hypersensitivity; Female; Haptens; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Male; Middle Aged; Penicillins; Polylysine; Serum Albumin, Human; Urticaria; Young Adult | 2016 |
Amoxicillin, a potential epileptogenic drug.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Electroencephalography; Epilepsy; Humans | 2016 |
Effective determination of ampicillin in cow milk using a molecularly imprinted polymer as sorbent for sample preconcentration.
Topics: Amoxicillin; Ampicillin; Animals; beta-Lactams; Ethylene Glycol; Feasibility Studies; Methacrylates; Milk; Molecular Imprinting; Oxacillin; Penicillin G; Polymers; Reproducibility of Results | 2017 |
How artificial is the antibiotic resistance definition?
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Industry; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Politics; Practice Guidelines as Topic; Streptococcus pneumoniae; Terminology as Topic | 2017 |
Immediate hypersensitivity to penicillins. Identification of a new antigenic determinant.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Drug-Related Side Effects and Adverse Reactions; Epitopes; Humans; Hypersensitivity, Immediate; Immunoassay; Immunoglobulin E; Penicillins; Sensitivity and Specificity | 2018 |
Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity | 2018 |
Profound underdosing of β-lactams in patients with sickle-cell disease.
Topics: Amoxicillin; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefotaxime; Humans; Prospective Studies | 2018 |
Photolysis of four β‑lactam antibiotics under simulated environmental conditions: Degradation, transformation products and antibacterial activity.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Biodegradation, Environmental; Penicillin V; Photolysis; Piperacillin; Sunlight; Waste Disposal, Fluid; Water Pollutants, Chemical | 2019 |
Pig liver esterases PLE1 and PLE6: heterologous expression, hydrolysis of common antibiotics and pharmacological consequences.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Carboxylesterase; Catalysis; Humans; Hydrolysis; Liver; Proteomics; Swine | 2019 |
β-Lactam Exposure Triggers Reactive Oxygen Species Formation in Enterococcus faecalis via the Respiratory Chain Component DMK.
Topics: Amoxicillin; beta-Lactams; Enterococcus faecalis; Escherichia coli; Oxidative Stress; Reactive Oxygen Species; Vitamin K 2 | 2019 |
Evaluating drug fever to beta-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Fever; Humans; Male; Middle Aged | 2020 |
Differentiating Between β-Lactam-Induced Serum Sickness-Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Drug Hypersensitivity; Exanthema; Female; Humans; Male; Serum Sickness; Skin Tests; Virus Diseases | 2021 |
Beta-lactams susceptibility testing of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis isolates: a comparative assessment of Etest and disk diffusion methods against broth dilution.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sensitivity and Specificity | 2020 |
Boosting the sensitivity of in vitroβ-lactam allergy diagnostic tests.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbonates; Cohort Studies; Diagnostic Tests, Routine; Diamines; Drug Hypersensitivity; Female; Haptens; Humans; Lactams; Male; Middle Aged; Penicillin G; Serum Albumin, Human; Structure-Activity Relationship; Substrate Specificity | 2020 |
Delayed positive drug provocation tests to beta-lactams with flare-up reactions of skin tests sites.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefatrizine; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Middle Aged; Penicillins; Skin Tests; Young Adult | 2021 |
The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Cell Wall; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Larva; Lipopolysaccharides; Membrane Proteins; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Animal; Moths; Mutation; Octoxynol; Oxacillin; Penicillin-Binding Proteins; Peptidoglycan; Phenotype; Staphylococcal Infections; Teichoic Acids; Virulence | 2021 |
Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2021 |
Screening for β-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Microbial Sensitivity Tests; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Reproducibility of Results; Streptococcus anginosus | 2022 |
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin | 2022 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus | 2022 |
Positive drug provocation with beta-lactam antibiotics in children: A single test may not be enough.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Infant; Male | 2022 |
Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Data Mining; Molecular Docking Simulation; Monobactams; Penicillins; Tazobactam | 2022 |
Amoxicillin and thiamphenicol treatments may influence the co-selection of resistance genes in the chicken gut microbiota.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Chickens; Drug Resistance, Microbial; Gastrointestinal Microbiome; RNA, Ribosomal, 16S; Thiamphenicol | 2022 |
Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB).
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Drug Monitoring; Endocarditis; Endocarditis, Bacterial; Enterococcus; Humans; Male; Middle Aged; Retrospective Studies; Streptococcus | 2023 |
Diagnostic utility of basophil CD203c expression in β-lactam allergy.
Topics: Amoxicillin; Anti-Bacterial Agents; Basophils; beta-Lactams; Drug Hypersensitivity; Humans; Hypersensitivity; Immunoglobulin E; Monobactams | 2023 |
Degradation of Penicillinic Antibiotics and β-Lactamase Enzymatic Catalysis in a Biomimetic Zn-Based Metal-Organic Framework.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biomimetics; Catalysis; Metal-Organic Frameworks; Penicillins; Zinc | 2023 |
Molecular evidence of β-lactam resistant Staphylococcus aureus in equids with respiratory tract infections: Frequency and resistance modulation strategy.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |